Request Deal Involvement
Biocon to acquire Biocon Biologics Limited from Serum Institute Life Sciences, Tata Capital, Viatris, Activ Pine and Mylan for $6.315bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors to financial advisors
S&R Associates
financial advisors
Morgan Stanley
financial advisors
Hsbc
tax advisors
Ernst & Young
legal advisors
Shardul Amarchand Mangaldas & Co
financial advisors
Ambit
financial advisors
Citigroup
legal advisors
Khaitan & Co
legal advisors
Cravath Swaine & Moore
or
Principals
vendor
TATA CAPITAL
bidder
BIOCON LIMITED
vendor
SERUM INSTITUTE OF INDIA
target
BIOCON BIOLOGICS LTD
vendor
MYLAN NV
vendor
ACTIV PINE LLP
vendor
VIATRIS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2026 Datasite